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alaria may be relatively high in some Central American
ountries, including several large or middle size cities. Trav-
lers to malaria-risk areas, including infants, children, and
ormer residents of Mexico and Central America, should take
n antimalarial drug. There is no chloroquine resistance in
entral America, so this drug can still be recommended for
ravelers to these countries. Malaria is not a risk in most of
he Caribbean islands, but P. falciparum is endemic to most
f Haiti and some areas of the Dominican Republic, where
here is variable to low risk. Malaria in these areas is still
ensitive to chloroquine, which is therefore recommended
or prevention.
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Yellow fever (YF) is an arboviral disease caused by a
irus from Flaviviridae family and genus Flavivirus endemic
n tropical regions of Africa and South America. Transmis-
ion occurs after infected mosquito bite, genera Aedes
nd Haemogogus. Urban YF was eradicated in Brazil in
942, since than sporadic wild transmission has been main-
ained in country endemic area. From 1989 to 2008, 546
uman conﬁrmed cases YF were reported including 241
eaths (case fatality rate 44, 1%) in Brazil. During this
eriod north and midwestern region were responsible for
he highest number of cases registering human cases almost
very year. Beginning in 1999, YF virus underwent a geo-
p
T
c
aternational Congress on Infectious Diseases (ICID) Abstracts
raphic expansion into southeast, south and midwestern
egion - Federal District, Goias, Sao Paulo, Minas Gerais,
arana and Rio Grande do Sul states — related to out-
reaks in areas that were silent for several decades and
utside Amazon area. This study describes the re-emergence
f YF virus in enzootic cycles involving mosquitoes, pri-
ates and humans cases in midwestern, southeast and
outh region during 2008 and 2009. During this period
nd explosive recording of monkey’s death was registry
y health authorities with laboratory conﬁrmed epizootics.
uman cases were associated with leisure and work activ-
ties in rural areas and occurred among unvaccinated
erson. Brazilian Ministry of Health considered it as a public
ealth event of national concern according to the Inter-
ational Health Regulations (2005). Epidemiological control
easures were adopted including entomologic control
nd assessments, monkey deaths surveillance investigation
nd mass vaccination campaigns were implemented. YF
accine-associated viscerotropic and neurotropic disease
ere reported. Those activities were important to estab-
ish an effective intervention to control and prevent future
utbreaks. Public health authority’s interest has been awak-
ned by reporting early identiﬁcation of YF virus circulation
o understand the potential geographic virus expansion and
eemergence.
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Chagas disease and leishmaniasis are the most impor-
ant vector-borne protozoan NTDs. Almost all of the 8-9
illion cases of Chagas disease (with approximately 50,000
ew cases annually) occur in poor rural and, increasingly,
any new urban and peri-urban areas of Latin America. Of
hese cases, an estimated 5.4 million people will develop
hronic Chagas heart disease, while 900,000 will develop
egaesophagus and megacolon. In LAC, the burden of dis-
ase caused by Trypanosoma cruzi infection is between ﬁve
o ten times greater than malaria. Chagas disease is dis-
roportionately represented among people living in poverty.
he disease has also emerged or re-emerged in areas of
onﬂict in Chiapas State, Mexico and Colombia. The major
pproaches to control including improved case manage-
